Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 14, 2023; 29(14): 2134-2152
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2134
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2134
Figure 3 Anti-inflammatory effect of carrimycin in mice detected by enzyme-linked immunosorbent assay.
A: Interleukin-4 (IL-4) expression in the intestine; B: IL-4 expression in the lung; C: IL-4 expression in the liver; D: IL-4 expression in the spleen; E: IL-4 expression in the kidney; F: IL-1β expression in the intestine; G: IL-1β expression in the lung; H: IL-1β expression in the liver; I: IL-1β expression in the spleen; J: IL-1β expression in the kidney. IL: Interleukin.
- Citation: Li XY, Luo YT, Wang YH, Yang ZX, Shang YZ, Guan QX. Anti-inflammatory effect and antihepatoma mechanism of carrimycin. World J Gastroenterol 2023; 29(14): 2134-2152
- URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2134.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2134